nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR2A—narcolepsy	0.813	1	CbGaD
Cinitapride—HTR2A—enteric nervous system—narcolepsy	0.0195	0.29	CbGeAlD
Cinitapride—HTR2A—locus ceruleus—narcolepsy	0.0129	0.192	CbGeAlD
Cinitapride—HTR4—Serotonin receptors—HTR2A—narcolepsy	0.00741	0.0617	CbGpPWpGaD
Cinitapride—HTR2A—pons—narcolepsy	0.00741	0.11	CbGeAlD
Cinitapride—HTR2A—autonomic nervous system—narcolepsy	0.00683	0.102	CbGeAlD
Cinitapride—HTR4—brain—narcolepsy	0.00606	0.0904	CbGeAlD
Cinitapride—HTR4—Amine ligand-binding receptors—HRH3—narcolepsy	0.00556	0.0463	CbGpPWpGaD
Cinitapride—HTR4—G alpha (s) signalling events—P2RY11—narcolepsy	0.00406	0.0338	CbGpPWpGaD
Cinitapride—HTR4—Monoamine GPCRs—HTR2A—narcolepsy	0.0033	0.0275	CbGpPWpGaD
Cinitapride—HTR4—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00277	0.0231	CbGpPWpGaD
Cinitapride—HTR1A—brainstem—narcolepsy	0.00277	0.0413	CbGeAlD
Cinitapride—HTR1A—forebrain—narcolepsy	0.00267	0.0398	CbGeAlD
Cinitapride—HTR1A—Serotonin receptors—HTR2A—narcolepsy	0.00236	0.0196	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00234	0.0195	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00234	0.0195	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00226	0.0188	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00201	0.0167	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00201	0.0167	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00194	0.0161	CbGpPWpGaD
Cinitapride—HTR4—G alpha (s) signalling events—NPS—narcolepsy	0.0019	0.0158	CbGpPWpGaD
Cinitapride—HTR1A—Amine ligand-binding receptors—HRH3—narcolepsy	0.00177	0.0147	CbGpPWpGaD
Cinitapride—HTR1A—midbrain—narcolepsy	0.00176	0.0263	CbGeAlD
Cinitapride—HTR2A—brainstem—narcolepsy	0.00165	0.0246	CbGeAlD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00165	0.0137	CbGpPWpGaD
Cinitapride—HTR2A—forebrain—narcolepsy	0.00159	0.0237	CbGeAlD
Cinitapride—HTR2A—Amine ligand-binding receptors—HRH3—narcolepsy	0.00153	0.0127	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—HCRTR1—narcolepsy	0.00153	0.0127	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—HCRTR2—narcolepsy	0.00153	0.0127	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—P2RY11—narcolepsy	0.00147	0.0123	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00147	0.0122	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Other—P2RY11—narcolepsy	0.00143	0.0119	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00128	0.0106	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—HCRT—narcolepsy	0.00125	0.0104	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00125	0.0104	CbGpPWpGaD
Cinitapride—HTR2A—medulla oblongata—narcolepsy	0.00115	0.0172	CbGeAlD
Cinitapride—HTR4—GPCR ligand binding—PENK—narcolepsy	0.00112	0.0093	CbGpPWpGaD
Cinitapride—HTR1A—brain—narcolepsy	0.00111	0.0165	CbGeAlD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00109	0.00911	CbGpPWpGaD
Cinitapride—HTR2A—midbrain—narcolepsy	0.00105	0.0157	CbGeAlD
Cinitapride—HTR1A—Monoamine GPCRs—HTR2A—narcolepsy	0.00105	0.00874	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—TRH—narcolepsy	0.00095	0.00791	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000907	0.00755	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000907	0.00755	CbGpPWpGaD
Cinitapride—HTR1A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.000883	0.00735	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—HCRTR2—narcolepsy	0.000863	0.00718	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—HCRTR1—narcolepsy	0.000863	0.00718	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—P2RY11—narcolepsy	0.000834	0.00694	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—HRH3—narcolepsy	0.000833	0.00694	CbGpPWpGaD
Cinitapride—HTR2A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.000833	0.00693	CbGpPWpGaD
Cinitapride—HTR2A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.000833	0.00693	CbGpPWpGaD
Cinitapride—HTR2A—G alpha (q) signalling events—P2RY11—narcolepsy	0.000804	0.00669	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—HCRTR2—narcolepsy	0.000784	0.00652	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—HCRTR1—narcolepsy	0.000784	0.00652	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—P2RY11—narcolepsy	0.000757	0.0063	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000745	0.0062	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000745	0.0062	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.000745	0.0062	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.000745	0.0062	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000719	0.00599	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.000719	0.00599	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—HCRT—narcolepsy	0.000709	0.0059	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—NPS—narcolepsy	0.000691	0.00575	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—TAC1—narcolepsy	0.000691	0.00575	CbGpPWpGaD
Cinitapride—HTR2A—G alpha (q) signalling events—HCRT—narcolepsy	0.000684	0.00569	CbGpPWpGaD
Cinitapride—HTR2A—brain—narcolepsy	0.000661	0.00985	CbGeAlD
Cinitapride—HTR4—Signaling by GPCR—HCRT—narcolepsy	0.000644	0.00536	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000644	0.00536	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000644	0.00536	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000638	0.00531	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000638	0.00531	CbGpPWpGaD
Cinitapride—HTR4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000637	0.0053	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—PENK—narcolepsy	0.000632	0.00526	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000622	0.00517	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000616	0.00513	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.000612	0.00509	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—PENK—narcolepsy	0.000588	0.00489	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—PENK—narcolepsy	0.000574	0.00477	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000551	0.00459	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000551	0.00459	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000546	0.00454	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—TRH—narcolepsy	0.000537	0.00447	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000533	0.00443	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000524	0.00436	CbGpPWpGaD
Cinitapride—HTR2A—G alpha (q) signalling events—TRH—narcolepsy	0.000518	0.00431	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000504	0.00419	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—TRH—narcolepsy	0.000488	0.00406	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—HCRTR2—narcolepsy	0.000486	0.00405	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—HCRTR1—narcolepsy	0.000486	0.00405	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—HRH3—narcolepsy	0.000471	0.00392	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—P2RY11—narcolepsy	0.000469	0.00391	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000467	0.00389	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.000463	0.00386	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HCRTR1—narcolepsy	0.000463	0.00385	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HCRTR2—narcolepsy	0.000463	0.00385	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000453	0.00377	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—P2RY11—narcolepsy	0.000447	0.00372	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—HRH3—narcolepsy	0.000438	0.00365	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000435	0.00362	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—HRH3—narcolepsy	0.000428	0.00356	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—HCRTR2—narcolepsy	0.00042	0.0035	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—HCRTR1—narcolepsy	0.00042	0.0035	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—HTR2A—narcolepsy	0.000415	0.00346	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000407	0.00338	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—P2RY11—narcolepsy	0.000406	0.00338	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000404	0.00336	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—HCRT—narcolepsy	0.000399	0.00332	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000397	0.00331	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—NPS—narcolepsy	0.00039	0.00325	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—TAC1—narcolepsy	0.00039	0.00325	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HCRT—narcolepsy	0.00038	0.00316	CbGpPWpGaD
Cinitapride—HTR2A—G alpha (q) signalling events—TAC1—narcolepsy	0.000376	0.00313	CbGpPWpGaD
Cinitapride—HTR2A—G alpha (q) signalling events—NPS—narcolepsy	0.000376	0.00313	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—PENK—narcolepsy	0.000356	0.00296	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—NPS—narcolepsy	0.000354	0.00295	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—TAC1—narcolepsy	0.000354	0.00295	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000351	0.00292	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000348	0.0029	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—HCRT—narcolepsy	0.000345	0.00287	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000343	0.00286	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PENK—narcolepsy	0.000339	0.00282	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000337	0.0028	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000337	0.0028	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—PENK—narcolepsy	0.000307	0.00256	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000303	0.00252	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—TRH—narcolepsy	0.000302	0.00252	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000301	0.0025	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000289	0.0024	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000289	0.0024	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TRH—narcolepsy	0.000288	0.0024	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000275	0.00229	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000275	0.00229	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—P2RY11—narcolepsy	0.000265	0.00221	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—HRH3—narcolepsy	0.000265	0.00221	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—TRH—narcolepsy	0.000261	0.00218	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HRH3—narcolepsy	0.000253	0.0021	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HCRTR1—narcolepsy	0.000249	0.00208	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HCRTR2—narcolepsy	0.000249	0.00208	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000249	0.00208	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000249	0.00208	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—P2RY11—narcolepsy	0.000241	0.00201	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000237	0.00198	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000237	0.00198	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—HTR2A—narcolepsy	0.000235	0.00195	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000229	0.00191	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—HRH3—narcolepsy	0.000229	0.00191	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—HCRT—narcolepsy	0.000226	0.00188	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—TAC1—narcolepsy	0.00022	0.00183	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—NPS—narcolepsy	0.00022	0.00183	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000215	0.00179	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000215	0.00179	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—HTR2A—narcolepsy	0.000213	0.00177	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NPS—narcolepsy	0.000209	0.00174	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TAC1—narcolepsy	0.000209	0.00174	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—P2RY11—narcolepsy	0.000208	0.00173	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HCRT—narcolepsy	0.000205	0.0017	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000203	0.00169	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PENK—narcolepsy	0.000201	0.00167	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—HCRT—narcolepsy	0.000195	0.00162	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—TAC1—narcolepsy	0.00019	0.00158	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—NPS—narcolepsy	0.00019	0.00158	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PENK—narcolepsy	0.000183	0.00152	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HCRT—narcolepsy	0.000177	0.00147	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PENK—narcolepsy	0.000174	0.00145	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000174	0.00145	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—TRH—narcolepsy	0.000171	0.00142	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PENK—narcolepsy	0.000158	0.00131	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—TRH—narcolepsy	0.000155	0.00129	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—HRH3—narcolepsy	0.00015	0.00125	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—TRH—narcolepsy	0.000148	0.00123	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HCRTR2—narcolepsy	0.000147	0.00123	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HCRTR1—narcolepsy	0.000147	0.00123	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—P2RY11—narcolepsy	0.000142	0.00118	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HRH3—narcolepsy	0.000136	0.00113	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—TRH—narcolepsy	0.000134	0.00112	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—HTR2A—narcolepsy	0.000132	0.0011	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00013	0.00108	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—HRH3—narcolepsy	0.000129	0.00108	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HCRTR2—narcolepsy	0.000127	0.00106	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HCRTR1—narcolepsy	0.000127	0.00106	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HTR2A—narcolepsy	0.000126	0.00105	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—TAC1—narcolepsy	0.000124	0.00103	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—NPS—narcolepsy	0.000124	0.00103	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—P2RY11—narcolepsy	0.000123	0.00102	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HCRT—narcolepsy	0.000121	0.00101	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HRH3—narcolepsy	0.000118	0.000979	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—NPS—narcolepsy	0.000113	0.000939	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—TAC1—narcolepsy	0.000113	0.000939	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000113	0.000937	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PENK—narcolepsy	0.000108	0.000898	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—TAC1—narcolepsy	0.000107	0.000893	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—NPS—narcolepsy	0.000107	0.000893	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HCRT—narcolepsy	0.000105	0.00087	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—NPS—narcolepsy	9.74e-05	0.000811	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—TAC1—narcolepsy	9.74e-05	0.000811	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PENK—narcolepsy	9.32e-05	0.000776	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TRH—narcolepsy	9.17e-05	0.000763	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HRH3—narcolepsy	8.04e-05	0.000669	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TRH—narcolepsy	7.92e-05	0.000659	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—HTR2A—narcolepsy	7.47e-05	0.000622	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HRH3—narcolepsy	6.95e-05	0.000578	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HTR2A—narcolepsy	6.79e-05	0.000565	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TAC1—narcolepsy	6.66e-05	0.000555	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NPS—narcolepsy	6.66e-05	0.000555	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TAC1—narcolepsy	5.76e-05	0.000479	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NPS—narcolepsy	5.76e-05	0.000479	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HTR2A—narcolepsy	4.01e-05	0.000334	CbGpPWpGaD
